An Pan - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock An Pan's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
An Pan
Verified
Contributor, BMJ Open Diabetes Research & Care
Beats
Politics , Science , Climate , Environment
Beauty, fitness, business, relationships, home, cooking, fashion
Content
Modifiable risk factors and plasma proteomics in relation to complications of type 2 diabetes - Nature Communications
By Ruyi Li, Jun Liu, Kai Zhu, An Pan, Yunfei Liao| Nature Verified AbstractA comprehensive assessment of combined modifiable risk factors with common complications of type 2 diabetes (T2D) is lacking, and the potential role of proteomics remains unclear. Here, we examine the associations of cardiovascular health (CVH) score and degree of risk factor control with common diabetic complications using data from the UK Biobank (n = 14,102). Furthermore, we explore the mediation effects of plasma proteomics in a subset with proteomic data (n = 1287).
Compact and broadband polarization splitter-rotator on thin-film lithium niobate minimized with the fast quasi-adiabatic algorithm
By Jinsong Xia, An Pan, Cheng Zeng, Xiangyu Meng| Optica Verified Polarization splitter-rotators (PSRs) are crucial for on-chip polarization-division multiplexing (PDM) systems. Here, we design and experimentally demonstrate a compact and broadband PSR based on adiabatic mode evolution on a thin-film lithium niobate (TFLN) platform. A novel, to the best of our knowledge, quasi-adiabatic algorithm is proposed to minimize the device size.
Modifiable risk factors and plasma proteomics in relation to complications of type 2 diabetes - Nature Communications
By Ruyi Li, Jun Liu, Kai Zhu, An Pan, Yunfei Liao| Nature Verified AbstractA comprehensive assessment of combined modifiable risk factors with common complications of type 2 diabetes (T2D) is lacking, and the potential role of proteomics remains unclear. Here, we examine the associations of cardiovascular health (CVH) score and degree of risk factor control with common diabetic complications using data from the UK Biobank (n = 14,102). Furthermore, we explore the mediation effects of plasma proteomics in a subset with proteomic data (n = 1287).
Company Info
BMJ Open Diabetes Research & Care